Bookmark this page — the only place tracking real acceptance speed, FWCI and field-normalized citation data for this journal.

Journal decision profile

iScience

Biochemistry, Genetics and Molecular Biology · Medicine

Cell PressNetherlandseISSN 2589-0042

Visit homepage

4.52026 metrics scoreOpenAlex · CC0

161dmedian speedlatest 97 articles

$3,150publishing cost*verify with journal

Journal Metrics Score

Journal Metrics ScoreThe visible value is the 2026Journal Metrics Score: citations in the most recent complete year to the journal's works from the two prior years, divided by the number of those works — from OpenAlex open data (CC0).

2026

4.5

Journal Metrics Score 2026 · 2021–2024 window citedness 5.20.

Speed

SpeedMedian calendar days from manuscript received to accepted. It includes revision time and is not the journal's time to first decision.

PUBMED

161 days

Submission → acceptance · median · 97/100 recent articles.

APC / cost*

APC / cost*Costs are indicative and may exclude taxes, waivers, society discounts, or article-type charges. Always verify the journal's official website.

VERIFY

$3,150

Indicative journal-level APC. Verify current charges, taxes, waivers, discounts, and article-type fees with the journal.

At a glance

Journal decision profile

A visual summary for comparison—not a single black-box star rating.

Relative profile

Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible

Metrics Score

Metrics ScoreThe 2026 Journal Metrics Score, normalized within a comparable journal cohort for this preview.

4.52026 · OPENALEX

Source output rank

Source output rankLifetime journal-wide output rank among OpenAlex sources associated with the journal’s leading topic.

#50 / 1,351LIFETIME OUTPUT

Highly cited papers

Highly cited papersRecent works in the global top 10% after normalization by work type, year, and subfield.

25.1%FIELD-NORMALIZED TOP 10%

Field-normalized impact

Field-normalized impactMedian FWCI, where 1.0 is the expected citation level for comparable work.

1.36MEDIAN FWCI

Review speed

Review speedMedian submission-to-acceptance time from qualified PubMed records.

161 daysMEDIAN

Recent output

Recent outputAverage annual publication volume across the complete analysis window.

2351 / yr2021–2024 AVG

Cost efficiency

Cost efficiencyNo score is assigned without a reliable journal-level cost.

—NOT SCORED

Field-normalized top 10% share25.1%

2360 of 9,403 works · same type, year & subfield

Field-normalized top 1% share1.5%

141 works · same type, year & subfield

Median FWCI1.36×

Above field-year expectation

Source output rank#50

of 1,351 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 1.36, so its typical recent paper runs about 36% above its field benchmark.

What does Top 10% Share mean?

25.1% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Submission to acceptance time (publication speed)

Among 97 recent articles with complete PubMed dates, the median time from received to accepted was 161 days. It includes revisions and is not the journal's time to first decision.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 2018–2025

2562018

5552019

12502020

16132021

21372022

27922023

28612024

28062025

Recent work-type mix

9,403 OpenAlex works · 2021–2024

Article99.5%

Review0.4%

Retraction0.1%

OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.

Fit signals

Topics and research coverage

OpenAlex topics show the research communities this journal serves.

Leading OpenAlex topics

2021–2024 works

SARS-CoV-2 and COVID-19 Research244

Single-cell and spatial transcriptomics99

Gut microbiota and health94

Immune Cell Function and Interaction91

RNA Research and Splicing82

Mitochondrial Function and Pathology81

Neural dynamics and brain function80

RNA modifications and cancer80

Neuroscience and Neuropharmacology Research79

Adipose Tissue and Metabolism72

Methodology: OpenAlex snapshot 2026-08-09. FWCI, percentile badges, topics, and type mix use 9,403 works published 2021–2024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.